protein
| binding of PVR with CD226 negatively regulates osteoclast formation and cellular fusion process may be inhibited by the PVR-mediated signaling |
|
interacting with CD96 (interaction may be crucial in developmental processes) |
|
TIGIT, a new protein expressed by T and NK cells binds to PVR and PVR-like receptors and inhibits T cell activity indirectly through the manipulation of dendritic cells activity |
|
TIGIT binds to PVR on the dendritic cell surface, driving them to a more tolerogenic phenotype |
|
TIGIT is a novel inhibitory receptor, interacting with two ligands: PVR and NECTIN2 and to inhibit human NK-cell cytotoxicity |
|
TIGIT/PVR engagement suppresses interferon-gamma (IFNG1) production of NK cells |
|
TIGIT was selectively up-regulated on NK cells, along with high expression of its ligand, poliovirus receptor (PVR/CD155), on hepatocytes during liver regeneration |
|
PVR engages the activating receptor CD226, the inhibitory receptor TIGIT, and the CD96 receptor with both activating and inhibitory functions |
|
TIGIT, upon interaction with either of its two ligands, NECTIN2 or poliovirus receptor (PVR), inhibits activation of T and NK cells |